Mammofield: Mammofield

by William Olivadoti

non-contact, non-invasive, non-radiative experimental mammography research devices
Ticonderoga, NY United States Breast Cancer Cancer Diagnostics

All Team Company Patients Physicians Hospital Partners Mission Innovation Details Supporters Comments Updates

About our project

The problem we solve:
Early cancer cell detection

About our solution:
accidentally invented device; same recommended for cancer research by 2 University of California cancer researchers [one oncologist, one eye cancer specialist]; Two University cancer researchers recommended that mammofield® technology offers the possibility to be a reliable harbinger of cell-tumor screening as a complement to x-ray mammograms.; have one FDA regulatory expert, one M.S.E.E and one oncology biostatistician on board. Have large pension fund on board with matching co-investment. Recommended for melanoma clinical trials and also for early warning transplant organ failure by a NY medical college research oncologist.
Progress to date:

slow prototypes; fast units soon.


About Our Team

Creator: William Olivadoti
Location: New York
Bio: biometrics device inventor
Title: CEO

About Our Company

The William Olivadoti Company
Location: 53 Shore Airport Rd.
Box 212
Ticonderoga, New York 12883
US
Product Stage: Prototype/MVP
YTD Sales: Working on it
Employees: 1-2

How We Help Patients

Catch the cancer at cell level

How We Help Physicians

The mammofield technology can detect veryveryvery 
small bioelectric fields in a non-contact,
 non-invasive and non-radiative manner.

Cf. 
 Dr. Mchael Levin`s research on cell bioelectric field signatures 
 at Tufts wherein he speaks about in situ cancer cell bioelectric signatures; mammofield is extra-situ and is non-contact detection of cell biolectric field signatures  at a distance:

http://www.pddnet.com/news/2013/02/bioelectric-signals-
can-be-used-detect-early-cancer?et_cid=3070549&et_rid=45588976&linkid
=http%3a%2f%2fwww.pddnet.com%2fnews%2f2013%2f02%2fbioelectric-signals
-can-be-used-detect-early-cancer


How We Help Hospitals

complementary to mammograms
 


How We Help Partners

Complementary to mammograms


Innovation Details

Intellectual Property Summary

patented; also second patent to be pending

Clinical Information

medical device

Regulatory Status

have one FDA regulatory expert on board for clinicals

How we will use the funds raised

Funds to be spent for first research, clinical trials and commercial units/systems 

Thank You

Have pension fund committed and ready to match this  project funding or any fundings up to $1.5 million USD.  Have 2 east coast university hospital cancer research centers considering possible collaboration.

Supporters

Comments

Login to post your comment!
Click here to Login

Updates

  • 4 oncologists now have recommended this project
    One oncologist from Univ. Of Cal. Med Ctr. & one cancer researcher from Univ. of Cal -Berkeley, have recommended this project for skin, tissue and beast cancer research; two oncologists from Albany Medical College have recommended the project for melanoma clinical trials. How many more cancer researchers do I need to get to recommend this project before it ever gets off the ground?

  • error
    should read "for skin, tissue and breast cancer research"

$ 0

pledged of $ 20,000 goal

  • 36 Days left

20

Interest
Score

0

Adoption
Score


Rewards All contributions are tax-deductible.